|
[1]
|
Ford, B., Dore, M. and Koehn, T.R. (2026) Recurrent Ischemic Stroke: Prevention Strategies. American Family Physician, 113, 57-69.
|
|
[2]
|
Li, J., Pan, Y., Xu, J., Li, S., Wang, M., Quan, K., et al. (2021) Residual Inflammatory Risk Predicts Poor Prognosis in Acute Ischemic Stroke or Transient Ischemic Attack Patients. Stroke, 52, 2827-2836. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Pan, Y., Li, Z., Li, J., Jin, A., Lin, J., Jing, J., et al. (2021) Residual Risk and Its Risk Factors for Ischemic Stroke with Adherence to Guideline-Based Secondary Stroke Prevention. Journal of Stroke, 23, 51-60. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Li, X., Li, Z. and Wu, N. (2025) Remnant Cholesterol and Residual Risk of Atherosclerotic Cardiovascular Disease. Reviews in Cardiovascular Medicine, 26, Article No. 25985. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Feng, Q., Li, H., Zhang, R., Sun, L., Zhang, S., Chen, Y., et al. (2024) Elevated Remnant Cholesterol Is a Risk Factor for Acute Ischemic Stroke. Journal of Stroke and Cerebrovascular Diseases, 33, Article ID: 107773. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Varbo, A., Benn, M., Tybjærg-Hansen, A., Jørgensen, A.B., Frikke-Schmidt, R. and Nordestgaard, B.G. (2013) Remnant Cholesterol as a Causal Risk Factor for Ischemic Heart Disease. Journal of the American College of Cardiology, 61, 427-436. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Nordestgaard, B.G. (2016) Triglyceride-Rich Lipoproteins and Atherosclerotic Cardiovascular Disease: New Insights from Epidemiology, Genetics, and Biology. Circulation Research, 118, 547-563. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Varbo, A., Benn, M. and Nordestgaard, B.G. (2014) Remnant Cholesterol as a Cause of Ischemic Heart Disease: Evidence, Definition, Measurement, Atherogenicity, High Risk Patients, and Present and Future Treatment. Pharmacology & Therapeutics, 141, 358-367. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Burnett, J.R., Hooper, A.J. and Hegele, R.A. (2020) Remnant Cholesterol and Atherosclerotic Cardiovascular Disease Risk. Journal of the American College of Cardiology, 76, 2736-2739. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Sampson, M., Ling, C., Sun, Q., Harb, R., Ashmaig, M., Warnick, R., et al. (2020) A New Equation for Calculation of Low-Density Lipoprotein Cholesterol in Patients with Normolipidemia and/or Hypertriglyceridemia. JAMA Cardiology, 5, 540-548. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Wang, D., Zhang, Z., Zhang, Y., Chen, S., Qu, N., Li, H., et al. (2025) Two‐Year Changes in Remnant Cholesterol and Stroke Risk in the Chinese Population: A Prospective Cohort Study. Journal of the American Heart Association, 14, e38559. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Jiang, X., Zhuang, J., Juan, Y., Zheng, X. and Zhang, H. (2024) Association between Remnant Cholesterol and the Risk of Cardiovascular Disease in Chinese Population. Journal of Stroke and Cerebrovascular Diseases, 33, Article ID: 107825. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
刘星雨, 杜慧杰, 莫佳丽, 等. 残余胆固醇水平与缺血性脑卒中复发风险的关联性及其预测价值研究[J]. 中国全科医学, 2024, 27(26): 3227-3231.
|
|
[14]
|
Wu, Z., Jiang, Y., Guo, Z., Li, P., Zheng, Y., Wang, Y., et al. (2024) Remnant Cholesterol Traits and Risk of Stroke: A Multivariable Mendelian Randomization Study. PNAS Nexus, 3, pgae33. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Chen, X. and Li, L. (2023) Remnant Cholesterol, a Valuable Biomarker for Assessing Arteriosclerosis and Cardiovascular Risk: A Systematic Review. Cureus, 15, e44202. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
Sandesara, P.B., Virani, S.S., Fazio, S. and Shapiro, M.D. (2018) The Forgotten Lipids: Triglycerides, Remnant Cholesterol, and Atherosclerotic Cardiovascular Disease Risk. Endocrine Reviews, 40, 537-557. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
Varbo, A., Benn, M., Tybjærg-Hansen, A. and Nordestgaard, B.G. (2013) Elevated Remnant Cholesterol Causes both Low-Grade Inflammation and Ischemic Heart Disease, Whereas Elevated Low-Density Lipoprotein Cholesterol Causes Ischemic Heart Disease without Inflammation. Circulation, 128, 1298-1309. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
Duewell, P., Kono, H., Rayner, K.J., Sirois, C.M., Vladimer, G., Bauernfeind, F.G., et al. (2010) NLRP3 Inflammasomes Are Required for Atherogenesis and Activated by Cholesterol Crystals. Nature, 464, 1357-1361. [Google Scholar] [CrossRef] [PubMed]
|
|
[19]
|
Ding, W.Y., Protty, M.B., Davies, I.G. and Lip, G.Y.H. (2021) Relationship between Lipoproteins, Thrombosis, and Atrial Fibrillation. Cardiovascular Research, 118, 716-731. [Google Scholar] [CrossRef] [PubMed]
|
|
[20]
|
Rouland, A., Masson, D., Lagrost, L., Vergès, B., Gautier, T. and Bouillet, B. (2022) Role of Apolipoprotein C1 in Lipoprotein Metabolism, Atherosclerosis and Diabetes: A Systematic Review. Cardiovascular Diabetology, 21, Article No. 272. [Google Scholar] [CrossRef] [PubMed]
|
|
[21]
|
Bell-Anderson, K.S. (2008) Adipokines: Linking Obesity and Cardiovascular Disease. Expert Review of Endocrinology & Metabolism, 3, 61-73. [Google Scholar] [CrossRef] [PubMed]
|
|
[22]
|
Zhang, P., Zhang, Z., Li, D., Han, R., Li, H., Ma, J., et al. (2023) Association of Remnant Cholesterol with Intracranial Atherosclerosis in Community-Based Population: The ARIC Study. Journal of Stroke and Cerebrovascular Diseases, 32, Article ID: 107293. [Google Scholar] [CrossRef] [PubMed]
|
|
[23]
|
Wang, A., Tian, X., Zuo, Y., Wu, J., Tang, H., Wang, Y., et al. (2021) Association of Remnant Cholesterol with Intra-and Extra-Cranial Atherosclerosis in Chinese Community Population. Atherosclerosis Plus, 46, 20-26. [Google Scholar] [CrossRef] [PubMed]
|
|
[24]
|
Qian, S., You, S., Sun, Y., Wu, Q., Wang, X., Tang, W., et al. (2021) Remnant Cholesterol and Common Carotid Artery Intima-Media Thickness in Patients with Ischemic Stroke. Circulation: Cardiovascular Imaging, 14, e10953. [Google Scholar] [CrossRef] [PubMed]
|
|
[25]
|
Yang, X.H., Zhang, B.L., Cheng, Y., Fu, S.K. and Jin, H.M. (2023) Association of Remnant Cholesterol with Risk of Cardiovascular Disease Events, Stroke, and Mortality: A Systemic Review and Meta-Analysis. Atherosclerosis, 371, 21-31. [Google Scholar] [CrossRef] [PubMed]
|
|
[26]
|
Ridker, P.M. (2016) Residual Inflammatory Risk: Addressing the Obverse Side of the Atherosclerosis Prevention Coin. European Heart Journal, 37, 1720-1722. [Google Scholar] [CrossRef] [PubMed]
|
|
[27]
|
Nordestgaard, A.T. and Nordestgaard, B.G. (2025) Remnant Cholesterol Lowering in Cardiovascular Disease Risk Reduction in Statin, Ezetimibe, and PCSK9 Inhibitor Trials: Meta-Regression Analyses. European Journal of Preventive Cardiology, zwaf337. [Google Scholar] [CrossRef] [PubMed]
|
|
[28]
|
Pintó, X., Fanlo, M., Esteve, V. and Millán, J. (2023) Remnant Cholesterol, Vascular Risk, and Prevention of Atherosclerosis. Clínica e Investigación en Arteriosclerosis (English Edition), 35, 206-217. [Google Scholar] [CrossRef]
|
|
[29]
|
Chen, J., Wu, Q., Liu, H., Hu, W., Zhu, J., Ji, Z., et al. (2025) Predictive Value of Remnant Cholesterol Inflammatory Index for Stroke Risk: Evidence from the China Health and Retirement Longitudinal Study. Journal of Advanced Research, 76, 543-552. [Google Scholar] [CrossRef] [PubMed]
|
|
[30]
|
Li, J., Yan, K., Zhu, P., Xu, J., Tang, X., Li, Y., et al. (2024) Association between Multiple Inflammatory Biomarkers and Remnant Cholesterol Levels in Patients with Percutaneous Coronary Intervention: A Large-Scale Real-World Study. Nutrition, Metabolism and Cardiovascular Diseases, 34, 377-386. [Google Scholar] [CrossRef] [PubMed]
|